Qualigen Therapeutics, Inc. completed a private placement on September 29, 2025, raising $41 million through the sale of 337,432 shares of common stock at $2.246 each and 17,783 shares of Series B Convertible Preferred Stock, intended to pay down debt and establish cryptocurrency operations.